MX2014010686A - Preparacion terapeutica y proceso para elaborar dicha preparacion terapeutica. - Google Patents

Preparacion terapeutica y proceso para elaborar dicha preparacion terapeutica.

Info

Publication number
MX2014010686A
MX2014010686A MX2014010686A MX2014010686A MX2014010686A MX 2014010686 A MX2014010686 A MX 2014010686A MX 2014010686 A MX2014010686 A MX 2014010686A MX 2014010686 A MX2014010686 A MX 2014010686A MX 2014010686 A MX2014010686 A MX 2014010686A
Authority
MX
Mexico
Prior art keywords
therapeutic preparation
preparing
therapeutic
preparation
platelet concentrate
Prior art date
Application number
MX2014010686A
Other languages
English (en)
Inventor
Andrea Bignotti
Chiara Turelli
Original Assignee
Andrea Bignotti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrea Bignotti filed Critical Andrea Bignotti
Publication of MX2014010686A publication Critical patent/MX2014010686A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una preparación terapéutica (1) que contiene aceite ozonizado y un concentrado de plaquetas (2), mezclados según una proporción de mezcla entre los volúmenes del concentrado de plaquetas (2) y del aceite ozonizado (3), esencialmente en el rango entre 2 y 4.
MX2014010686A 2012-03-06 2013-03-05 Preparacion terapeutica y proceso para elaborar dicha preparacion terapeutica. MX2014010686A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000338A ITMI20120338A1 (it) 2012-03-06 2012-03-06 Preparato terapeutico e procedimento di preparazione di detto preparato terapeutico
PCT/IB2013/051739 WO2013132428A1 (en) 2012-03-06 2013-03-05 Therapeutic preparation and process for preparing said therapeutic preparation

Publications (1)

Publication Number Publication Date
MX2014010686A true MX2014010686A (es) 2015-04-10

Family

ID=45999974

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014010686A MX2014010686A (es) 2012-03-06 2013-03-05 Preparacion terapeutica y proceso para elaborar dicha preparacion terapeutica.

Country Status (18)

Country Link
US (1) US20150071893A1 (es)
EP (1) EP2822562A1 (es)
JP (1) JP2015512886A (es)
CN (1) CN104254335A (es)
AP (1) AP2014007991A0 (es)
AU (1) AU2013229128A1 (es)
CA (1) CA2869364A1 (es)
EA (1) EA201400985A1 (es)
IT (1) ITMI20120338A1 (es)
MA (1) MA20150243A1 (es)
MD (1) MD20140110A2 (es)
MX (1) MX2014010686A (es)
NZ (1) NZ700661A (es)
PH (1) PH12014502261A1 (es)
SG (1) SG11201405500YA (es)
TN (1) TN2014000378A1 (es)
WO (1) WO2013132428A1 (es)
ZA (1) ZA201407214B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2644650C2 (ru) 2014-12-01 2018-02-13 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток и способ его получения
RU2708329C2 (ru) 2016-05-31 2019-12-05 Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" Материал стволовых клеток, композиции и способы применения
CN106615687A (zh) * 2016-11-21 2017-05-10 肖成运 一种新型的复合饲料添加剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336488A (en) * 1991-08-07 1994-08-09 American Cyanamid Company Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines
JPH0971536A (ja) * 1995-07-03 1997-03-18 Nippon Telegr & Teleph Corp <Ntt> 生物細胞含有液凍結乾燥装置
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
US6472210B1 (en) * 1997-11-14 2002-10-29 Bonetec Corporation Polymer scaffold having microporous polymer struts defining interconnected macropores
JP3993981B2 (ja) * 1998-06-22 2007-10-17 サイトメディックス・インコーポレーテッド 改良された濃縮血小板創傷治癒剤に対する特許の適用
DE69915204T2 (de) * 1998-08-17 2004-07-29 Pfizer Products Inc., Groton Stabilisierte Proteinzusammensetzung
CA2296997A1 (en) * 2000-01-18 2001-07-18 Vasogen Ireland Limited Treatment of congestive heart failure
TR200401573T4 (tr) * 2000-02-29 2004-08-23 Pfizer Products Inc. Stabilize edilmiş granülosit koloni uyarıcı faktör
RU2201756C2 (ru) * 2001-03-11 2003-04-10 Вятская государственная сельскохозяйственная академия Способ профилактики и лечения мастита у коров
WO2002100455A2 (en) * 2001-06-08 2002-12-19 Baylor College Of Medicine Use of ozone for the prevention of infection caused by medical devices
RU2238097C2 (ru) * 2002-05-24 2004-10-20 Вятская государственная сельскохозяйственная академия Препарат для лечения и профилактики эндометрита и мастита у коров и способ его приготовления
JP2005112798A (ja) * 2003-10-08 2005-04-28 Atsuya Ogata 動物の炎症又は創傷を治療するための外用治療薬及び治療方法
BRPI0520280A2 (pt) * 2005-05-10 2009-04-28 Us Of America Dept Of Veteran terapia de disfunÇÕes renais e falÊncia méltipla de àrgços com cÉlulas-tronco mesenquimais e meio condicionado por exposiÇço a cÉlulas-tronco mesenquimais
BE1017155A3 (nl) * 2006-06-01 2008-03-04 Sanomedical Bvba Wondverzorgingsproduct.
CN201029956Y (zh) * 2007-05-29 2008-03-05 张全有 动物乳腺炎治疗仪
JP2009235004A (ja) * 2008-03-27 2009-10-15 J Hewitt Kk 細胞組織増加促進方法及び肌問題改善方法並びにこれらに用いるキット

Also Published As

Publication number Publication date
JP2015512886A (ja) 2015-04-30
US20150071893A1 (en) 2015-03-12
PH12014502261A1 (en) 2014-12-15
ITMI20120338A1 (it) 2013-09-07
AP2014007991A0 (en) 2014-10-31
CA2869364A1 (en) 2013-09-12
AU2013229128A1 (en) 2014-10-23
EA201400985A1 (ru) 2015-04-30
SG11201405500YA (en) 2014-10-30
MA20150243A1 (fr) 2015-07-31
ZA201407214B (en) 2015-10-28
MD20140110A2 (ro) 2015-03-31
WO2013132428A1 (en) 2013-09-12
NZ700661A (en) 2016-08-26
TN2014000378A1 (en) 2015-12-21
EP2822562A1 (en) 2015-01-14
CN104254335A (zh) 2014-12-31

Similar Documents

Publication Publication Date Title
PH12015502392A1 (en) A capsule for preparing edible compositions
PH12015501753A1 (en) Enhanced stability of novel liquid compositions
PH12016500953A1 (en) Tricyclic compounds as anticancer agents
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
MY183637A (en) Compounds and uses thereof for the modulation of hemoglobin
GB201106750D0 (en) Novel compounds
IN2015DN03322A (es)
GB201106743D0 (en) Novel compounds
MX2015001526A (es) Agentes de sosten sinteticos y agentes de sosten monodispersos y metodos para la elaboracion de los mismos.
MX2013012896A (es) Compuestos novedosos como moduladores de proteina cinasas.
MX2015012414A (es) Sal de omecamtiv mecarbilo y proceso para preparar la sal.
BR112013026297A2 (pt) ésteres de resina de colofônia para não tecidos
NZ628433A (en) Chitosan-derived compositions
IL233825A (en) H1-indazole-3-carboxamide compounds, preparations containing them and their use in the preparation of medicines
MX2014012164A (es) Composiciones a base de probioticos y un complejo de polen de abejas/arcilla, su preparacion y sus usos en nutricion y en terapeutica.
TN2016000003A1 (en) New isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them
WO2013134251A3 (en) Anionic exchange-hydrophobic mixed mode
PH12014502261A1 (en) Therapeutic preparation and process for preparing the said therapeutic prepapration
IN2015DN00085A (es)
GB201209015D0 (en) Novel compounds
MX350122B (es) Tinturas dispersas, su preparación y su uso.
MX2014006201A (es) Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse.
IN2014MN01492A (es)
WO2013163562A3 (en) Compositions and methods for treating ptsd and related diseases
GEP20156373B (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease